Expert Review of Hematology
Volume 17, 2024 - Issue 1-3
Open access
470
Views
0
CrossRef citations to date
0
Altmetric
Original Research
18F-FDG-PET/CT response after first-line treatment as a prognostic factor for survival in peripheral T-cell lymphoma: a Spanish retrospective study
Raul Cordobaa Lymphoma Unit, Department of Haematology, Health Research Institute IIS-FJD, Fundación Jiménez Díaz University Hospital, Madrid, SpainCorrespondence[email protected]
View further author information
, View further author information
Joaquín Sánchez-Garcíab Hematology Department Department, IMIBIC Hospital Universitario Reina Sofía, UCO, Cordoba, Andalucía, SpainView further author information
, Eva Domingo-Domenechc Hematology Department, Institut Català D’oncologia, IDIBELL, L’Hospitalet de Llobregat, Barcelona, SpainView further author information
, Javier López Jiménezd Hematology Department, Hospital Universitario Ramón y Cajal, Madrid, SpainView further author information
, Antonio Martínez Pozoe Pathology Department, Hospital Clinic, Institut d’Investigacions Biomediques August Pi i Sunyer (IDIBAPS), CIBERONC, Universitat de Barcelona, Barcelona, SpainView further author information
, Cecilia Carpiof Department of Haematology, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron University Hospital (HUVH), Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, SpainView further author information
, Ángeles Bendañag Hematology Department, Complexo Hospitalario Universitario de Santiago de Compostela, La Coruña, SpainView further author information
, Ana Julia Gonzálezh Hematology Department, Hospital Universitario Central de Asturias, Oviedo, SpainView further author information
, Sonia González de Villambrosiai Hematology Department, Hospital Universitario Marqués de Valdecilla, Santander, SpainView further author information
, José Gómez Codinaj Medical Oncology Department, Hospital Universitari i Politecnic La Fe, Valencia, SpainView further author information
, Belén Navarrok Hematology Department, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, SpainView further author information
, Guillermo Rodríguezl Hematology Department, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS)/Universidad de Sevilla, Seville, SpainView further author information
, Andrea Navesm Medical Department, Takeda Farmacéutica España S.A, Madrid, SpainView further author information
, Lourdes Baezam Medical Department, Takeda Farmacéutica España S.A, Madrid, SpainView further author information
& Alejandro Martín García-Sanchon Hematology Department, Hospital Universitario de Salamanca, IBSAL, CIBERONC, Salamanca, SpainView further author information
show all
Pages 95-100
|
Received 20 Jun 2023, Accepted 25 Jan 2024, Published online: 07 Feb 2024
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.